Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
78.90
P/B ratioShare price divided by book value per share.
2.70
P/S ratioMarket value divided by annual revenue.
2.55
PEG ratioP/E divided by the earnings growth rate.
1.20
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
31.11
EV / RevenueEnterprise value against annual revenue.
2.98
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
1.27%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
27.19%
Operating marginRevenue left after operating costs.
3.89%
Net marginRevenue left after every cost, including tax and interest.
3.04%
Return on equityProfit as a percentage of shareholders’ equity.
3.39%
Return on assetsProfit as a percentage of total assets.
2.03%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.26
Quick ratioThe same, excluding inventory.
0.92
Debt to equityTotal borrowings against shareholders’ equity.
0.57
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.10
Book value per shareShareholders’ equity divided by shares outstanding.
$2.92
Shares outstandingShares currently issued.
559,363,183
Market capitalisationShare price times shares outstanding.
$4.41B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
2,084
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
18.00%
Payout ratioShare of profit paid out as dividends.
What is Henan Taloph Pharmaceutical Stock Co.,Ltd's P/E ratio?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) trades on a price-to-earnings ratio of 78.90.
What is Henan Taloph Pharmaceutical Stock Co.,Ltd's return on equity?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) reports a return on equity of 3.39%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Henan Taloph Pharmaceutical Stock Co.,Ltd carry?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) has a debt-to-equity ratio of 0.57, which compares total borrowings with shareholders' equity.
What is Henan Taloph Pharmaceutical Stock Co.,Ltd's profit margin?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) keeps 3.04% of revenue as net profit after every cost, including tax and interest.